Brokers say these ASX 100 shares are buys right now

These high-quality shares could be just what your portfolio needs.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While the ASX 100 index may not be as well-known or widely followed as the benchmark ASX 200 index, what it lacks in attention it makes up for in quality.

Among the 100 companies included in the index are some of the biggest and brightest that Australia has to offer. But which ASX 100 shares are buys?

Two that could be worth considering according to analysts are listed below. Here's why they rate these ASX 100 shares as buys:

A young investor working on his ASX shares portfolio on his laptop.

Image source: Getty Images

Cochlear Limited (ASX: COH)

The first ASX 100 share that could be a buy is Cochlear.

It is a leading manufacturer and distributor of cochlear implantable devices for hearing impaired globally. It offers three main products: Cochlear implants, Baha bone conduction implants, and Cochlear Wireless Accessories.

Goldman Sachs believes Cochlear would be a top option for investors right now. Particularly given that trading conditions have improved materially now COVID headwinds are easing. It said:

Looking forward, we continue to express a general preference for the device/drug names over the service providers in the current environment, on the basis of: i) stronger pricing power; ii) more assured volume profiles; iii) more resilient/expanding market shares; and iv) stronger balance sheets.

We believe Cochlear screens well on these fundamental factors, and largely avoids the margin uncertainties prevalent across other verticals. We expect a sequential improvement in momentum through 2H23 (further elective volume improvement and new processor launch momentum, potentially tempered by some moderation in Acoustics). We forecast above guidance in FY23E (GSe: $306m vs. $290-305m) and believe shares will now be further supported by a newly announced multi-year buyback program (GSe: $75m/year).

Its analysts currently have a buy rating and $265.00 price target on its shares.

Seek Ltd (ASX: SEK)

Another ASX 100 share that could be a buy is Seek.

It operates an online employment classifieds platform across 12 countries. It has three main business segments: SEEK Employment, SEEK Learning, and SEEK International.

Morgans is positive on the company. Its analysts believe Seek will benefit from a number of tailwinds that lead to increased reliance on the company's products and services. It explains:

Of the classifieds players, we continue to see SEEK as the one with the most relative upside, a view that's based on the sustained listings growth we've seen over the period. The tailwinds that have driven elevated job ads (~210k currently, broadly flat on the robust pcp) and strong FY22 result appear to still remain in place, i.e. subdued migration, candidate scarcity and the drive for greater employee flexibility. With businesses looking to grow headcount in the coming months and job mobility at historically high levels according to the RBA, we see these favourable operating conditions driving increased reliance on SEEK's products.

Morgans has an add and $28.40 price target on Seek's shares.

Motley Fool contributor James Mickleboro has positions in Seek. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear and Seek. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: Mesoblast, Mineral Resources, and Woolworths shares

Analysts have given their verdict on these shares. Let's see what they are saying.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

These top ASX 200 shares could rise 30% to 40%

Analysts are predicting big things from these shares. Let's find out why.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: Netwealth, PLS, and Reliance shares

Morgans has given its verdict on these shares. Let's see what the broker is saying.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A panel of formidable business people stand in a group with serious looks on their faces as if in judgement of what's before them.
Broker Notes

3 ASX shares to buy: experts

In new notes, brokers say these ASX stocks are good buys today.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Bell Potter is tipping a 40% return from this ASX 200 share

A 40% return could be on the cards for buyers of this share.

Read more »

Woman checking bottle expiry dates.
Broker Notes

Here's why Morgans just upgraded Woolworths shares

The supermarket giant just received a boost from Morgans.

Read more »